Moderate AS With ‘At Risk Features: The EXPAND TAVR II Trial

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Medtronic; Admedus; W.L. Gore & Associates